VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Children aged 2-16 with a parent/guardian          │ Children aged 3-16 with a parent/guardian          │     100 │
│ (hereafter termed parent) reported history of      │ (hereafter termed parent) reported history of      │         │
│ allergy to a penicillin antibiotic in which the    │ allergy to a penicillin antibiotic in which the    │         │
│ reported allergic reaction occurred at least six   │ reported allergic reaction occurred at least six   │         │
│ months prior to the current PED visit              │ months prior to the current PED visit              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Only children well enough to be discharged to home │ Only children well enough to be discharged to home │     100 │
│ at the conclusion of the PED visit are eligible    │ at the conclusion of the PED visit are eligible    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Children will be excluded if they have a history   │ Children will be excluded if they have a history   │     100 │
│ of developmental delay or inability to communicate │ of developmental delay or inability to communicate │         │
│ the effects of an allergic reaction (non-verbal)   │ the effects of an allergic reaction (non-verbal)   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any contraindication to allergy testing will also  │ Any contraindication to allergy testing will also  │     100 │
│ result in exclusion                                │ result in exclusion                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ (i.e. history of a severe allergic reaction to     │ (i.e. history of a severe allergic reaction to     │     100 │
│ skin tests                                         │ skin tests                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ anaphylaxis in the past six weeks                  │ anaphylaxis in the past six weeks                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ child has a history of a condition that requires a │ child has a history of a condition that requires a │     100 │
│ beta blocker medicine for cardiac conditions, high │ beta blocker medicine for cardiac conditions, high │         │
│ blood pressure, migraine headaches, or eye drops   │ blood pressure, migraine headaches, or eye drops   │         │
│ for glaucoma (e.g. propranolol, metoprolol,        │ for glaucoma (e.g. propranolol, metoprolol,        │         │
│ atenolol and Timoptic®, or Betoptic® eye drops)    │ atenolol and Timoptic®, or Betoptic® eye drops)    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Children who present to the PED with a rash,       │ Children who present to the PED with a rash,       │     100 │
│ vomiting or current asthma symptoms including      │ vomiting or current asthma symptoms including      │         │
│ coughing, wheezing or breathing problems will also │ coughing, wheezing or breathing problems will also │         │
│ be excluded to ensure these do not mask reactions  │ be excluded to ensure these do not mask reactions  │         │
│ to an oral challenge                               │ to an oral challenge                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ During this pilot study, we will exclude non-      │ During this pilot study, we will exclude non-      │     100 │
│ English speaking families. However, in subsequent  │ English speaking families. However, in subsequent  │         │
│ studies we will include the non-English speaking   │ studies we will include the non-English speaking   │         │
│ population                                         │ population                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Children who are wards of the state, in foster     │ Children who are wards of the state, in foster     │     100 │
│ care or police custody or detention will be        │ care or police custody or detention will be        │         │
│ excluded                                           │ excluded                                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Children with any basal condition (trauma,         │ Children with any basal condition (trauma,         │     100 │
│ infection, minor accidents, etc..) will be able to │ infection, minor accidents, etc..) will be able to │         │
│ participate in the study provided they and their   │ participate in the study provided they and their   │         │
│ family are willing and do not meet the above-      │ family are willing and do not meet the above-      │         │
│ mentioned exclusion criteria                       │ mentioned exclusion criteria                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients deemed too acutely ill for participation  │ Patients being admitted to the hospital or those   │      86 │
│ (triage level 1 or 2 or as determined by the ED    │ who are deemed too acutely ill for participation   │         │
│ patient care team) will be excluded from the study │ (triage level 1 or 2 or as determined by the ED    │         │
│                                                    │ patient care team) will be excluded from the study │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                  │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 2 Years  │ anaphylaxis in the past six weeks              │      37 │
├───────────────────────────────────┼────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 16 Years │ (i.e. history of a severe allergic reaction to │      38 │
│                                   │ skin tests                                     │         │
├───────────────────────────────────┼────────────────────────────────────────────────┼─────────┤
│ known pregnancy                   │ pregnancy                                      │      75 │
╘═══════════════════════════════════╧════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                     │   Score │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Children who present to the PED with a rash,       │ child took any antihistamine in the past three    │      41 │
│ vomiting or current asthma symptoms including      │ days [including diphenhydramine (Benadryl®),      │         │
│ coughing, wheezing or breathing problems will also │ cetirizine (Zyrtec®), loratadine (Claritin®),     │         │
│ be excluded to ensure these do not mask reactions  │ fexofenadine (Allegra®), levocetirizine (Xyzal®), │         │
│ to an oral challenge                               │ and desloratadine (Clarinex®)] or                 │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ known pregnancy                                    │ pregnancy                                         │      75 │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 91
Average Levenshtein Ratio of individual lines: 85.41176470588235
OverAll Ratio: 88.20588235294117
